Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
- PMID: 34901101
- PMCID: PMC8655114
- DOI: 10.3389/fnut.2021.662952
Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
Abstract
Low carbohydrate diets have a promising mechanistic rationale in the treatment of cancer with favorable preclinical data. The strongest data suggest synergistic effects of dietary interventions with traditional cancer therapies. Recent prospective clinical trials suggest that low carbohydrate diets are safely and feasibly added within a busy oncology clinic, with hopeful additive effects in treatment enhancement.
Keywords: cancer; carbohydrate restriction; chemotherapy; immunotherapy; ketogenic diet (KD); metabolism; radiation.
Copyright © 2021 Haskins, Cohen, Kotecha and Kaiser.
Conflict of interest statement
RK: Honorarium from Elsevier Inc., Elekta AB, Accuray Inc, Novocure Inc., and Viewray Inc. Research support unrelated to this study from Novocure Inc., Medtronic Inc., Blue Earth Diagnostics, GT Medical Technologies, AstraZeneca, Exelixis, and Viewray Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years [Internet]. (2019). Available online at: https://www.cancer.org/latest-news/facts-and-figures-2019.html (accessed January 30, 2021).
-
- Facts & Figures 2021 Reports Another Record-Breaking 1-Year Drop in Cancer Deaths [Internet]. (2021). Available online at: https://www.cancer.org/latest-news/facts-and-figures-2021.html (accessed January 30, 2021).
-
- American Cancer Society | Cancer Facts and Statistics [Internet] . (2021). Available online at: http://cancerstatisticscenter.cancer.org/ (accessed January 30, 2021).
Publication types
LinkOut - more resources
Full Text Sources